4//SEC Filing
KIRK SCOTT H MD 4
Accession 0001181431-09-041549
CIK 0001086939other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 6:14 PM ET
Size
21.1 KB
Accession
0001181431-09-041549
Insider Transaction Report
Form 4
NOVAMED INCNOVA
KIRK SCOTT H MD
Director
Transactions
- Sale
Common Stock
2009-08-25$4.50/sh−10,448$47,036→ 532,635 total(indirect: See Footnote 1) - Sale
Common Stock
2009-08-27$4.39/sh−23,000$101,037→ 504,735 total(indirect: See Footnote 1) - Sale
Common Stock
2009-08-26$4.39/sh−4,900$21,513→ 527,735 total(indirect: See Footnote 1)
Holdings
- 0
Stock Option (right to buy)
Exercise: $4.45Exp: 2014-03-16→ Common Stock (25,000 underlying) - 120,197
Common Stock
- 0
Stock Option (right to buy)
Exercise: $7.35Exp: 2017-02-21→ Common Stock (12,000 underlying) - 695,360(indirect: See Footnote 2)
Common Stock
- 0
Stock Option (right to buy)
Exercise: $0.83Exp: 2012-05-23→ Common Stock (100,000 underlying) - 0
Stock Option (right to buy)
Exercise: $5.96Exp: 2015-06-16→ Common Stock (15,000 underlying) - 0
Stock Option (right to buy)
Exercise: $6.87Exp: 2016-06-20→ Common Stock (15,000 underlying) - 0
Stock Option (right to buy)
Exercise: $2.75Exp: 2019-02-18→ Common Stock (20,000 underlying)
Footnotes (12)
- [F1]Represents shares of common stock held by Kirk Eye Center, S.C., of which Dr. Kirk is a shareholder. Dr. Kirk disclaims beneficial ownership of these shares, except to the extent of his proportionate pecuniary interest therein.
- [F10]These shares were sold in multiple transactions ranging from 4.36 to 4.50, inclusive. The reporting person undertakes to provide to NovaMed, Inc., and security holder of NovaMed, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the foregoing range.
- [F11]These shares were sold in multiple transactions ranging from 4.47 to 4.51, inclusive. The reporting person undertakes to provide to NovaMed, Inc., and security holder of NovaMed, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the foregoing range.
- [F12]These shares were sold in multiple transactions ranging from 4.35 to 4.47, inclusive. The reporting person undertakes to provide to NovaMed, Inc., and security holder of NovaMed, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price in the foregoing range.
- [F2]Represents shares of common stock held by Scott Kirk Family LLC. Dr. Kirk is the manager and a member of the LLC. Dr. Kirk disclaims beneficial ownership of these shares, except to the extent of his proportionate pecuniary interest therein.
- [F3]Subject to certain restrictions, 12,500 of these options vested on 11/23/02 with the remainder vesting 2,083 per month starting on 12/23/02.
- [F4]Subject to certain restrictions, 3,125 of these options vested on 9/16/04 with the remainder vesting 520 per month starting on 10/16/04.
- [F5]Subject to certain restrictions, 1,875 of these options vested on 12/17/05, with the remainder vesting 312 per month starting on 1/17/06.
- [F6]Subject to certain restrictions, 1,875 of these options vested on 12/20/06 with the remainder vesting 312 per month starting on 1/20/07.
- [F7]Subject to certain restrictions, 1,500 of these options vested on 8/21/07 with the remainder vesting 250 per month starting 9/21/07.
- [F8]Includes 10,250 restricted shares of common stock.
- [F9]Subject to certain restrictions, 2,500 of these options vested on 8/18/09 with the remainder vesting approximately 417 per month starting on 9/18/09.
Issuer
NOVAMED INC
CIK 0001086939
Entity typeother
Related Parties
1- filerCIK 0001205530
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 6:14 PM ET
- Size
- 21.1 KB